XXVIII Curso Intensivo Davidson-Mestman, Diabetes, Endocrinology and Cardiometabolic Diseases

Wednesday, December 9, 2026, 8:00 AM - Saturday, December 12, 2026, 5:30 PM, Hilton Aventura, Aventura , FL


AMA PRA Category 1 Credits™ (24.50 hours)

The XXVII Davidson-Mestman Intensive Course on Diabetes, Endocrinology and Cardiometabolic Diseases is the premier Endocrinology Congress reaching endocrinology specialists throughout Latin America, Spain and the USA.The course, commonly referred to as “Curso Intensivo,” will comprehensively address the daily challenges faced by physicians in clinical practice who treat patients with diabetes, cardiovascular disease, and endocrine disorders. The four-day “Curso Intensivo” lectures will be conducted in both English and Spanish and are designed for endocrinologists, internists, family doctors, and allied health care professionals

1. Apply principles of deiodinase biology and TSH physiology to individualize treatment decisions in patients with hypothyroidism.
2. Identify patients who should be evaluated for primary aldosteronism and select an evidence-based diagnostic and treatment approach.
3. Differentiate clinical and ultrasound features of thyroid nodules that warrant biopsy, surveillance, molecular evaluation, or referral.
4. Recognize the clinical and biochemical features of paraneoplastic Cushing syndrome and formulate an appropriate diagnostic and initial management plan.
5. Recognize the manifestations of SDH-deficient disease and incorporate appropriate genetic evaluation, surveillance, and management strategies into practice.
6. Formulate an appropriate diagnostic and treatment plan for patients with suspected adrenal insufficiency, including stress-dose management when indicated.
7. Select appropriate diabetes technologies based on patient characteristics and use device-generated data to improve glycemic management.
8. Avoid common diagnostic and therapeutic pitfalls in adrenal insufficiency and optimize acute and long-term management.
9. Apply current recommendations for blood pressure targets and antihypertensive therapy in patients with diabetes to reduce cardiovascular and renal risk.
10. Assess the clinical significance of lean mass loss during weight reduction and incorporate strategies to preserve muscle while treating obesity.
11. Compare current and emerging therapeutic approaches for MASH and apply a comprehensive management strategy for patients at risk of progressive liver disease.
12. Apply relevant updates from the AHA guidelines to improve cardiovascular risk reduction in patients with endocrine and metabolic disease.
13. Explain the role of adipose fibrosis in cardiorenal metabolic disease and evaluate emerging therapeutic implications for metabolic health.
14. Compare the mechanisms, clinical potential, and safety considerations of emerging incretin combination therapies for obesity and metabolic disease
15. Evaluate dietary strategies for metabolically unhealthy obesity and tailor nutrition recommendations to patients’ cardiometabolic risk profiles.

Register here.

 

The University of Miami Leonard M. Miller School of Medicine designates this Live Activity for a maximum of 24.50 of AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Cancellation Policy
Cancellations received in writing no less than 30 days before the course will be refunded, less a 20% administrative fee. No refunds will be made on cancellations received after that date.

University of Miami Healthcare System reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.

Accessibility Statement
 University of Miami Healthcare System is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Coordinator.

Conference Manager: Samantha Salas Talavera
Email: [email protected]

Mitigation of Relevant Financial Relationships

The University of Miami adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.